AU2016365219A1 - Compositions and methods for otologic prophylaxis and treatment - Google Patents

Compositions and methods for otologic prophylaxis and treatment Download PDF

Info

Publication number
AU2016365219A1
AU2016365219A1 AU2016365219A AU2016365219A AU2016365219A1 AU 2016365219 A1 AU2016365219 A1 AU 2016365219A1 AU 2016365219 A AU2016365219 A AU 2016365219A AU 2016365219 A AU2016365219 A AU 2016365219A AU 2016365219 A1 AU2016365219 A1 AU 2016365219A1
Authority
AU
Australia
Prior art keywords
patient
surfactant
ear
surfactant composition
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016365219A
Other languages
English (en)
Inventor
Sujana S. Chandrasekhar
Gregory J. Flesher
Alan J. Mautone
Catherine Crisp TURKEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eledon Pharmaceuticals Inc
Original Assignee
Novus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novus Therapeutics Inc filed Critical Novus Therapeutics Inc
Publication of AU2016365219A1 publication Critical patent/AU2016365219A1/en
Assigned to NOVUS THERAPEUTICS, INC. reassignment NOVUS THERAPEUTICS, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: Otic Pharma Inc.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2016365219A 2015-11-30 2016-11-30 Compositions and methods for otologic prophylaxis and treatment Abandoned AU2016365219A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562260732P 2015-11-30 2015-11-30
US201562260734P 2015-11-30 2015-11-30
US201562260742P 2015-11-30 2015-11-30
US62/260,734 2015-11-30
US62/260,732 2015-11-30
US62/260,742 2015-11-30
PCT/US2016/064190 WO2017095905A1 (en) 2015-11-30 2016-11-30 Compositions and methods for otologic prophylaxis and treatment

Publications (1)

Publication Number Publication Date
AU2016365219A1 true AU2016365219A1 (en) 2018-07-05

Family

ID=58778000

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016365219A Abandoned AU2016365219A1 (en) 2015-11-30 2016-11-30 Compositions and methods for otologic prophylaxis and treatment

Country Status (8)

Country Link
US (1) US20170151173A1 (enExample)
EP (1) EP3383369A4 (enExample)
JP (1) JP2018535277A (enExample)
KR (1) KR20180105129A (enExample)
AU (1) AU2016365219A1 (enExample)
CA (1) CA3006563A1 (enExample)
MX (1) MX2018006575A (enExample)
WO (1) WO2017095905A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020142420A1 (en) * 2018-12-31 2020-07-09 Novus Therapeutics, Inc. Novel surfactant-lipid alloy drug substance, methods of making the same, and pharmaceutical compositions comprising the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
US5954682A (en) * 1996-09-25 1999-09-21 Advanced Medical Instruments Therapeutic applicator apparatus and method
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
ATE271048T1 (de) * 1997-11-24 2004-07-15 Procter & Gamble 5-(2-imidazolinylamino)-benzimidazol derivate, deren herstellung und deren verwendung als .alpha.-adrenoceptor agonisten mit verbesserter metabolischer stabilität
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US8568790B2 (en) * 2006-05-31 2013-10-29 Medihoney Pty Ltd. Medicinal compositions containing honey
US8343464B2 (en) * 2010-04-30 2013-01-01 Burns Phillip E Composition and method for treating eustachian tube dysfunction
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
EA201590124A1 (ru) * 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Also Published As

Publication number Publication date
WO2017095905A1 (en) 2017-06-08
EP3383369A4 (en) 2019-06-12
US20170151173A1 (en) 2017-06-01
EP3383369A1 (en) 2018-10-10
KR20180105129A (ko) 2018-09-27
MX2018006575A (es) 2018-12-06
JP2018535277A (ja) 2018-11-29
CA3006563A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
Laube Devices for aerosol delivery to treat sinusitis
US7524512B2 (en) Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
Chandrasekhar et al. Otitis media: treatment with intranasal aerosolized surfactant
US20170151173A1 (en) Compositions and methods for otologic prophylaxis and treatment
Rosenfeld et al. Tympanostomy tube care and consequences
Grewal et al. Tuberculous otitis media presenting as complications: report of 18 cases
CA2108782C (en) Composition and method for treatment of patulous eustachian tube syndrome and atrophic rhinitis
US20110268669A1 (en) Composition and method for treating eustachian tube dysfunction
Rashid Rationale and feasibility of intranasal delivery of drugs to the eustachian tube orifice
Hatch et al. Treatment options in the child with a chronic cough
Na et al. Autoinflation After Tympanostomy Tube Extrusion in Otitis Media With Effusion: A Randomized Clinical Trial
RU2550966C1 (ru) Средство и способ лечения экссудативного среднего отита у детей
Syed et al. Acute management of croup in children
Fadhel et al. The role of n-acetylcysteine in the treatment of otitis media with effusion
Yehia Mostafa et al. Topical intranasal corticosteroids compared with oral steroids in the Treatment of Eustachian tube dysfunction in children
Peraza et al. Otolaryngological features in children with trisomy 21: a study of 171 patients at the Hospital Infantil de México Federico Gómez
MD1816Z (ro) Metodă de tratament al otitei seroase la copii
Menon et al. Efficacy of mometasone nasal spray in the treatment of otitis media with effusion in the pediatric age group: a preliminary study
Emerick et al. Common ENT disorders
Zając-Ratajczak et al. Assesment effectiveness of treatment Eustachian tube dysfunction using pneumatic inhaler AMSA
Thomas ENT surgery
Patel et al. Nebulised N-acetylcysteine used in acute tracheostoma obstruction.
FE et al. Trancient Horner
Özgencİl et al. Transient Horner's syndrome as a result of nasopharyngeal polyp traction-avulsion in a cat.
Brief Post Category→ Otolaryngology

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: NOVUS THERAPEUTICS, INC.

Free format text: FORMER NAME(S): OTIC PHARMA INC.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application